home / stock / pmcb / pmcb quote
Last: | $3.03 |
---|---|
Change Percent: | -56.71% |
Open: | $3.08 |
Close: | $3.03 |
High: | $3.14 |
Low: | $2.92 |
Volume: | 1,774,614 |
Last Trade Date Time: | 08/10/2021 04:41:14 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.03 | $3.08 | $3.03 | $3.14 | $2.92 | 1,774,614 | 08-10-2021 |
$7 | $9 | $7 | $10 | $6.57 | 27,350 | 08-09-2021 |
$0.0093 | $0.0092 | $0.0093 | $0.0094 | $0.0092 | 604,041 | 07-09-2021 |
$0.0093 | $0.0093 | $0.0093 | $0.01 | $0.009 | 3,429,775 | 07-08-2021 |
$0.0092 | $0.0093 | $0.0092 | $0.011 | $0.009 | 3,477,194 | 07-07-2021 |
$0.0099 | $0.01015 | $0.0099 | $0.014 | $0.0091 | 16,117,471 | 07-06-2021 |
$0.0105 | $0.00964 | $0.0105 | $0.0106 | $0.0093 | 3,595,116 | 07-05-2021 |
$0.0105 | $0.00964 | $0.0105 | $0.0106 | $0.0093 | 3,595,116 | 07-02-2021 |
$0.0097 | $0.0092 | $0.0097 | $0.011 | $0.0091 | 4,866,844 | 07-01-2021 |
$0.0108 | $0.01 | $0.0108 | $0.0108 | $0.009 | 6,006,989 | 06-30-2021 |
$0.0105 | $0.012 | $0.0105 | $0.012 | $0.0096 | 7,114,367 | 06-29-2021 |
$0.0112 | $0.014 | $0.0112 | $0.0143 | $0.0101 | 6,475,711 | 06-28-2021 |
$0.013 | $0.01375 | $0.013 | $0.0138 | $0.0128 | 5,150,959 | 06-25-2021 |
$0.0133 | $0.013 | $0.0133 | $0.014 | $0.0125 | 4,088,254 | 06-24-2021 |
$0.012 | $0.0089 | $0.012 | $0.0135 | $0.0087 | 13,522,811 | 06-23-2021 |
$0.0086 | $0.0071 | $0.0086 | $0.0086 | $0.0071 | 9,706,518 | 06-22-2021 |
$0.0075 | $0.007 | $0.0075 | $0.008 | $0.0069 | 10,072,442 | 06-21-2021 |
$0.0069 | $0.0087 | $0.0069 | $0.0087 | $0.0068 | 42,754,343 | 06-18-2021 |
$0.0087 | $0.0112 | $0.0087 | $0.0112 | $0.0075 | 40,563,859 | 06-17-2021 |
$0.0112 | $0.0115 | $0.0112 | $0.0115 | $0.0097 | 20,228,619 | 06-16-2021 |
News, Short Squeeze, Breakout and More Instantly...
PharmaCyte Biotech Inc. Company Name:
PMCB Stock Symbol:
OTCMKTS Market:
PharmaCyte Biotech Inc. Website:
Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder value PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”), today announced a $7 mi...